View Accessibility Controls Skip to main content

23 October 2023

Glaucoma UK celebrates the induction of Professor David ‘Ted’ Garway-Heath into The Ophthalmologist Power List Hall of Fame

Glaucoma UK is delighted to extend its warmest congratulations to Professor David ‘Ted’ Garway-Heath for his well-deserved induction into The Ophthalmologist Power List Hall of Fame. This prestigious accolade recognises Professor Garway-Heath’s outstanding contributions to ophthalmology, particularly in the field of glaucoma research.

Professor Garway-Heath is widely recognised for his pioneering work in developing essential diagnostic tools that have transformed the diagnosis and management of glaucoma. One of his most significant contributions is the creation of the Garway-Heath sectorisation map, a clinical diagnostic tool used worldwide to investigate the structure-function relationship in glaucoma.

Professor Garway-Heath is the author of over 200 scientific research papers. In 2006, he devised the ground-breaking United Kingdom Glaucoma Treatment Study (UKGTS). The UKGTS, the first placebo-controlled trial to assess the impact of intraocular-lowering treatment on vision preservation, became a landmark study in glaucoma management and the first glaucoma trial ever published in The Lancet.

Professor Garway-Heath said, “I’m honoured to be inducted into the Ophthalmologist’s Hall of Fame amongst colleagues who’ve made such significant contributions to patient care. […] The main motivation in my career has been to find new ways to improve the quality of life of patients. My goal has been to answer questions and uncertainties which matter to patients. Achievement requires teamwork. Throughout I have been supported by mentors, colleagues, and students at Moorfields and UCL Institute of Ophthalmology. I’d like to take this opportunity to thank Glaucoma UK, the UK patient organisation which supports my Chair at University College London.”

Professor Garway-Heath’s commitment to advancing our understanding of glaucoma and improving the lives of those affected by this sight-threatening condition remains unwavering. Currently, he is involved in research concerning effective diagnosis, monitoring, and management of glaucoma and has recently secured a major grant for a clinical trial focused on mitochondrial function in glaucoma.

For more information on Professor David ‘Ted’ Garway-Heath and his contributions to the field of glaucoma, please visit The Ophthalmologist Power List.